Back
CBS PREMIUM ACCESS

Identifying potential drug targets for non-alcoholic fatty liver disease: a drug target Mendelian randomization study

Session: Targets and markers of cardiometabolic disease
Topic: Drugs, Drug Targets
Speaker: Miss N. Hukerikar (London, GB)
Event: Frontiers in CardioVascular Biomedicine 2024

Congress Presentation

Add to my library

Like

About the speaker

Miss Nikita Hukerikar

University College London, London (United Kingdom of Great Britain & Northern Ireland)
0 follower

1 more presentation in this session

Circulating levels of amyloid-beta (1-40) peptide associate with cardiometabolic traits and risk for metabolic dysfunction-associated steatotic liver disease

Speaker: Doctor K. Sopova (Mannheim, DE)

Access
Abstract
Like
Thumbnail

Access the full session

Targets and markers of cardiometabolic disease

Speakers: Miss N. Hukerikar, Doctor K. Sopova
Access
Like
Thumbnail

About the event

Image

Frontiers in CardioVascular Biomedicine 2024

12 April - 14 April 2024

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources